Speaker illustration

Professor Avivit Cahn

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)

Avivit Cahn graduated from the Hebrew University and completed her residency and fellowship at the Hadassah Hebrew University Hospital, where she is a practicing endocrinologist. Prof. Cahn has led and participated in multiple clinical trials, including analysis of the SAVOR-TIMI 53 data, and membership of the steering committee of the DECLARE-TIMI-58. Research interests include big data and digital health, diabetic foot complications, personalized medicine and monogenic diabetes. She is currently the Head of the Israeli Diabetic Foot and Wound Healing Society. Prof. Cahn has authored over 80 publications and book chapters, is a reviewer for many diabetes journals, and is on the editorial board of Diabetes/Metabolism Research and Reviews. She has lectured at multiple forums and served on numerous advisory boards.

All diabetic patients should be treated with GLP1 and/or GIP agonists.

Event: ESC Congress 2022

Topic: Cardiovascular Pharmacotherapy

Session: Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes


SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session: Everything you need to know about SGLT2 inhibitors in heart failure


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb